Actin cytoskeleton disorders as a pro-survival signaling activator and a therapeutic biomarker in Diffuse Large B-cell Lymphoma (DLBCL).
2023/50/E/NZ5/00384
Keywords
Descriptors
- NZ5_03: Patogeneza chorób człowieka
- NZ5_07: Leczenie chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Instytut Hematologii i Transfuzjologii
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 4
Call
SONATA BIS 13 – announced on 2023-06-19
- Amount awarded
- 4 070 990 PLN
- Project start date
- 2024-06-20
- Project end date
- 2029-06-19
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.